Ritodrine

DB00867ApprovedWithdrawnSmall molecule

Ritodrine is an adrenergic beta agonist used to treat premature labor.

Mechanism: Ritodrine is beta-2 adrenergic agonist. It binds to beta-2 adrenergic receptors on outer membrane of myometrial cell, activates adenyl cyclase to increase the level of cAMP which decreases intracellular calcium and leads to a decrease of uterine contractions.
Curator reviewed
Primary indication: For the treatment and prophylaxis of premature labourCurator reviewed · 5 structured indications
Formula / weight: C₁₇H₂₁NO₃ · 287.359 g/mol (avg)
First approval: Canada, 1984
Code names: DU-21220

Resolves to

Compound

UNIII0Q6O6740JCAS26652-09-5ChEMBLCHEMBL489553ChEBI156577PubChem688570KEGGD02359

Clinical / RWD

RxNorm9392ATCG02CA01PharmGKBPA451258

Structure

InChIKeyIOVGROKTTNBUGK-SJKOYZFVSA-NSMILESC[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1

Targets

P07550ADRB2Q15746MYLKO75897SULT1C4

What you can answer from here — as of September 23, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

820Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

5Structured indicationsCondition, population, route and combination as fields, not prose

19ContraindicationsEach with its own population and attribute set

6Marketed productsAcross 3 countries and 3 labellers

1ATC codeIncluding every combination product, plus 21 drug categories

43+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ritodrine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In